PRP vs Stem Cell Conditioned Media: What Really Differs in Hair Regrowth?2026.06.30

“Which is better for hair loss—PRP or stem cell conditioned media?” This is one of the most common questions we receive from patients considering hair regenerative medicine. Although both approaches share the goal of activating hair follicles through growth factors, they differ fundamentally in their source material, quality control, and clinical response patterns. The distinction between “autologous blood-derived” and “cell-derived” is the very starting point of the comparison, and ignoring it makes any direct ranking misleading. In this article, we organize the medical differences between PRP and stem cell conditioned media across three axes: composition, mechanism, and evidence, including how they can be combined in clinical practice.

What is PRP — autologous “self-growth factors” extracted from your own blood

Preparation process and contents

PRP (Platelet-Rich Plasma) is a plasma fraction prepared by drawing the patient’s own blood and concentrating platelets through centrifugation. Platelet granules contain growth factors that orchestrate wound healing and tissue regeneration: PDGF (platelet-derived growth factor), TGF-β, VEGF (vascular endothelial growth factor), and EGF (epidermal growth factor).

Because PRP is prepared on the spot from fresh blood, it is intended for immediate scalp injection rather than long-term storage.

Mechanism on the scalp

When PRP is injected into the scalp, activated platelets release their stored growth factors simultaneously, stimulating angiogenesis around hair follicles, fibroblast activation, and the transition of follicles from telogen (resting) into anagen (growth).

Because the material is autologous, there is essentially no risk of immunologic allergy or rejection. The trade-off, however, is reproducibility: platelet count and growth factor yield vary noticeably based on the patient’s daily condition, blood draw technique, and preparation method.

What is stem cell conditioned media — the “liquid grown by cells” concept

What conditioned media actually is

Stem cell conditioned media is the collection of secreted products — growth factors, cytokines, exosomes, miRNAs, and more — released by human stem cells (derived from adipose tissue, dental pulp, or umbilical cord) into the culture medium during cultivation. The cells themselves are removed; what remains is the cocktail of molecules the cells secreted. This is an important distinction often misunderstood: it is not a therapy that injects stem cells, but one that uses the mixture of products stem cells produce.

Range of components

Stem cell conditioned media typically contains tens to hundreds of cytokines, including HGF (hepatocyte growth factor), IGF-1 (insulin-like growth factor), KGF (keratinocyte growth factor), SDF-1, TIMP, and collagen synthesis promoters. In addition, basic research increasingly demonstrates that nanoscale extracellular vesicles called exosomes can deliver gene-regulatory molecules (miRNAs) directly to follicular stem cells.

Because the product passes through an industrial culture process, lot-level quality control is feasible, giving it a reproducibility advantage over PRP.

The decisive differences between PRP and stem cell conditioned media

Source material and reproducibility

PRP uses the patient’s own blood as raw material, so platelet counts and growth factor concentrations fluctuate based on the patient’s condition, age, nutritional state, and draw technique. Stem cell conditioned media, on the other hand, is manufactured under standardized culture protocols, enabling lot management and quality testing — giving consistent dosing across repeated sessions.

For a long-term regenerative plan, whether you can deliver “the same treatment under nearly identical conditions every time” is not a trivial question.

Type and quantity of components

PRP’s active components are platelet-derived growth factors, roughly 10 to 20 species. Cultured conditioned media contains tens to hundreds of cytokines secreted by the source cells, plus exosome-mediated gene-regulatory signals — yielding a multi-layered effect on the follicular microenvironment.

The strength of conditioned media lies not in raw “amount of growth factor” but in “compositional diversity and signal layering.”

Where the evidence stands

PRP has been studied in multiple randomized controlled trials (RCTs) for AGA, with reported improvements in hair shaft thickness and density. For overall guidance on AGA treatment, the Japanese Dermatological Association guidelines remain a valuable reference when considering indications and combinations.

Stem cell conditioned media is currently supported mainly by basic research and clinical observation, with large-scale RCTs still accumulating. PRP leads in “historical evidence base”; conditioned media leads in “compositional design freedom” — this is a fair summary at present.

Can they be combined? How clinicians actually mix them

Because PRP and conditioned media act through complementary mechanisms, they are sometimes combined. One strategy is to create microchannels in the scalp with Morpheus8 and then deliver both — engaging hair follicles through autologous growth factors and exogenous cytokines simultaneously.

However, same-day combination is not always optimal. Spacing the two and varying the evaluation windows can make it easier to attribute which agent is driving which result. At our clinic, we frequently use a two-phase design: anchor the early treatment on one agent, then add the other after assessing response.

How to choose — a framework for treatment selection

The “autologous” nature of PRP brings the psychological comfort of using your own material and a low risk of immunologic rejection. The “cell-derived” nature of stem cell conditioned media offers reproducibility, compositional diversity, no need for blood draw, and shorter downtime.

Which to anchor your plan on depends on age, progression, prior treatment history, visit cadence, cost considerations, and your comfort with injections. The question is not “which one works”; the better question is “where does each fit within my overall treatment design.”

For more detailed treatment design and other options, please see our collection of hair regenerative medicine columns.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate (US Medical Licensing Qualification)

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

For inquiries, please contact us via DM / LINE / Website / Phone.